Global Debate on Nicotine Product Taxation

Regulations by 2FIRSTS.ai
Jan.09.2024
Global Debate on Nicotine Product Taxation
As e-cigarette and HNB products gain popularity, global debate over nicotine product tax rates intensifies, challenging policymakers to find a balance between economic and health considerations.

According to a report by Moneyweb on January 9th, the debate over nicotine product taxation is intensifying globally, as e-cigarettes and HNB products continue to gain popularity. This issue is causing disagreements between economists and public health experts, posing a challenge for countries on how to make rational decisions regarding the tax policies for these nicotine products.

 

Economists argue for considering both the costly economic consequences and individual freedoms when implementing taxation measures, to ensure that taxed prices reflect all costs associated with production and consumption. However, health experts lean towards prioritizing health impacts above economic effects, advocating for high taxes and regulations to reduce the detrimental effects of nicotine products on public health.

 

Currently, countries worldwide are striving to find a balance between the economy and public health. South Africa is reconsidering its tobacco and nicotine taxation policy, taking into account income inequality and public health challenges.

 

Economists believe that incorporating all net costs into the prices of nicotine products can provide consumers with accurate information to make informed decisions. On the other hand, health experts advocate for government intervention in the form of high taxes, bans, and regulations to limit the consumption of nicotine products in order to reduce their negative impact on health.

 

South Africa, a country grappling with income inequality and public health challenges, has opted for a risk-based nicotine product tax rate due to its fragile healthcare system and the heightened vulnerability of low-income individuals to non-communicable diseases. This decision has sparked a wide-ranging debate on its wisdom.

 

Overall, the global issue of nicotine taxation involves various interests and perspectives, with finding a balance between economic and health concerns being a common challenge for policymakers around the world.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
The U.S. FDA will launch a pilot program to accelerate reviews of nicotine pouch products from Philip Morris International, Altria, BAT’s Reynolds American, and Turning Point Brands, aiming to complete the process by December 2025. The move, driven by pressure from the Trump administration, seeks to address past multi-year approval delays. Nicotine pouches, the fastest-growing U.S. smoking alternative, are seen as lower-risk but raise youth appeal concerns.
Sep.08
China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco International (Hong Kong) recorded revenue of HKD 10.32 billion in the first half of 2025, up 18.5% year-on-year, with gross profit down 1.8%. Net profit attributable to shareholders was HKD 706 million, up 9.8% year-on-year. Revenue from the new tobacco export business was HKD 14.6 million, down 66.5% year-on-year.
Aug.22 by 2FIRSTS.ai
Product | Ploom AURA surges since May launch, sets JT’s fastest-ever 2-million-unit record
Product | Ploom AURA surges since May launch, sets JT’s fastest-ever 2-million-unit record
Japan Tobacco (JT) announced the first model in a new limited-color series for its heated-tobacco device Ploom AURA, “Amber Haze,” to be released in limited quantities from September 2 via the CLUB JT online store and Ploom Shops nationwide. As of August, Ploom AURA’s cumulative sales (shipment basis) have surpassed 2 million units—achieved at the fastest pace in JT’s history.
Sep.04 by 2FIRSTS.ai
Liverpool shop's licence revoked for selling illegal e-cigarettes
Liverpool shop's licence revoked for selling illegal e-cigarettes
A Liverpool store in the UK was selling illegal e-cigarettes and its licence was revoked. The city council successfully applied for a closure order, emphasizing that illegal e-cigarettes may contain banned ingredients and pose a health risk.
Sep.22 by 2FIRSTS.ai
Company | PMI Survey: 60% of U.S. Voters Support a “New Path” for Tobacco Control, Backing Policies that Encourage Switching to Lower-Risk Alternatives
Company | PMI Survey: 60% of U.S. Voters Support a “New Path” for Tobacco Control, Backing Policies that Encourage Switching to Lower-Risk Alternatives
An article on Philip Morris International’s (PMI) website indicates that U.S. likely voters generally hold reserved or negative views of the FDA’s performance on public health and tobacco regulation, with only about 36% expressing approval. Two nationwide polls show that more than six in ten respondents support reducing smoking rates through new approaches rather than relying solely on higher taxes and restrictions; over half support policies that encourage adult smokers to switch to non-combust
Sep.03 by 2FIRSTS.ai
Trump Administration Report: Vaping Designated as a Key Issue in the ‘Childhood Chronic Disease and Health Crisis’
Trump Administration Report: Vaping Designated as a Key Issue in the ‘Childhood Chronic Disease and Health Crisis’
The White House’s strategic report emphasizes that e-cigarettes are now a priority in addressing the “children’s health crisis.” The document states that vaping has become one of the key factors contributing to adolescent mental-health problems. The administration will task the Office of the Surgeon General with public education campaigns warning about the risks of alcohol, e-cigarettes, and THC; meanwhile, the Food and Drug Administration (FDA) and the Bureau of Alcohol, Tobacco, Firearms and E
Sep.10 by 2FIRSTS.ai